Drugs, Mental Health

Psychedelics could make mental health worse in people with a personality disorder

Various personality disorders might respond differently to psychedelics. For instance, people with histrionic personality disorder (excessive attention-seeking and emotional overreaction) or borderline personality disorder (emotional instability, intense relationships and fear of abandonment) might feel worse or more unstable. And those with schizotypal personality disorder (social anxiety, odd beliefs and eccentric behaviour) could become more paranoid. People with narcissistic personality disorder (excessive self-importance, lack of empathy, and need for admiration) may struggle with the self-reflective nature of psychedelics because they often have a hard time handling criticism.

Mental Health, Technology

Increasingly sophisticated AI systems can perform empathy, but their use in mental health care raises ethical questions

Some examples of AI applications include: screening tools in primary care settings, enhanced tele-therapy sessions and chatbots offering accessible 24/7 emotional support. These can act as bridges for anyone waiting for professional help and those hesitant to seek traditional therapy. However, this turn to emotion-AI comes with a host of ethical, social and regulatory challenges around consent, transparency, liability and data security.

Microscopc image of pollen
Allergies, Drugs, Immunology

Know Which Medication Is Right for Your Seasonal Allergies

An allergy is your body’s reaction to an otherwise innocent substance that it has identified as an invader. If you have allergies and encounter a trigger (allergen), your immune system fights it by releasing chemicals, such as histamine (hence the term “antihistamine”). Histamine causes symptoms, such as runny nose, itchy nose, sneezing, and itchy and watery eyes.

Dementia, End-of-Life Care

Hospice care for those with dementia falls far short of meeting people’s needs at the end of life

Strikingly, only 12% of Americans with dementia ever enroll in hospice. Among those who do, one-third are near death. This is in stark contrast to the cancer population: Patients over 60 with cancer enroll in hospice 70% of the time. In my experience caring for dementia patients, the underuse of hospice by dementia patients has more to do with how hospice is structured and paid for in the U.S. than it does patient preference or differences between cancer and dementia.